Joel Schuman

Chair, Department of Ophthalmology, NYU Langone Medical Center, New York

In 2001, Schuman and his team were the first to identify a molecular marker for human glaucoma, and, along with his colleagues Eric Swanson, James Fujimoto, Carmen Puliafito and David Huang, he invented OCT technology – receiving the Champalimaud Award for it. An NEI-funded principal investigator since 1995, his current research interests include imaging of the eye, laser-tissue interactions, aqueous outflow, and ocular pharmacology.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016